The Journal of Critical Care Medicine (May 2022)

Bronchoscopic Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage-induced Acute Respiratory Failure in MPO-ANCA Vasculitis: A Case Report

  • Smesseim Illaa,
  • Schaepman-Ruys Titia,
  • Duitman Jan Willem,
  • Vegting Yosta,
  • Raasveld Jorinde,
  • Hilhorst Marc,
  • Vlaar Alexander,
  • van Es Josien,
  • Bonta Peter

DOI
https://doi.org/10.2478/jccm-2022-0004
Journal volume & issue
Vol. 8, no. 2
pp. 123 – 125

Abstract

Read online

Diffuse alveolar haemorrhage (DAH) is a potentially life-threatening disease, characterized by diffuse accumulation of red blood cells within the alveoli. It can be caused by a variety of disorders. In case DAH results in severe respiratory failure, veno-venous extracorporeal membrane oxygenation (VV-ECMO) can be required. Since VV-ECMO coincides with the need for anticoagulation therapy, this results in a major clinical challenge in DAH patients with hemoptysis.

Keywords